Earnings Call · Q2 FY2024·2024-08-13

Q2 24EPS -18.57%·Rev n/aQ1 24EPS -4.48%·Rev n/aQ4 23EPS +25.61%·Rev n/aQ3 23EPS +25.00%·Rev n/a⚠ consensus missing

Mineralys Therapeutics, Inc. MLYS

Dan Ferry — Investor Relations

Jon Congleton — Chief Executive Officer

Adam Levy — Chief Financial Officer

−22.8%1d on move date−23.1% vs SPY3d−17.1%5d−11.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MLYS calls or request research access.

More MLYS calls Browse calls Request research access